Catalog No.
Product Name
Application
Product Information
Citations
-
Anti-Bacterial Agent
Fluoropolyoxin L is an antibacterial agent that exhibits potent inhibitory activity against Escherichia coli and Streptococcus faecalis. This compound is valuable for research applications focused on understanding bacterial resistance mechanisms and the development of novel antimicrobial strategies. Its targeted activity makes it an essential tool for microbiological studies and antibiotic research. -
Anti-Bacterial Agent
Oxirapentyn is an anti-bacterial agent primarily targeting Gram-positive bacteria and Mycobacterium species. While its antibacterial activity is relatively weak, it serves as a valuable compound for exploring bacterial resistance mechanisms and developing new antimicrobial strategies in pharmaceutical research. Its applications include studying the effects of bacterial infections and assessing potential therapeutic approaches in the field of infectious diseases. -
Antibacterial Agent
(Rac)-LY 255262 is a pyrazolidinone derivative that functions as an antibacterial agent. It effectively inhibits bacterial growth, making it suitable for research into antimicrobial resistance and the development of new antibacterial therapies. This compound is particularly useful for studies focused on the mechanisms of bacterial infections and potential therapeutic interventions. -
Antibacterial Agent
Agrimol C is a phloroglucinol derivative that exhibits antibacterial properties, primarily targeting Staphylococcus aureus. It demonstrates a minimum inhibitory concentration (MIC) of 50 μg/mL, indicating its effectiveness against this pathogenic strain. Agrimol C is suitable for research focused on infections and the development of antibacterial agents. -
Antibacterial Agent
Antibacterial Agent 135 is a potent antibacterial compound targeting multiple bacterial strains. It demonstrates inhibitory activity against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae, with an MIC greater than 64 μg/mL. This agent is valuable for research applications focusing on combating antibiotic-resistant infections and studying bacterial resistance mechanisms. -
Antibacterial Agent
4-Nitrosodiphenylamine is an antibacterial agent exhibiting significant activity against Erwinia amylovora, with an EC50 value of 5.715 mg/L. This compound is suitable for research applications focused on plant pathology and antibiotic development. Its effectiveness against specific bacterial strains makes it a valuable tool for studying antibacterial mechanisms and developing new therapeutic strategies. -
Antibacterial Agent
Ashimycin B is an antibacterial agent that functions as a Streptomycin analogue. It exhibits broad-spectrum antibacterial activity, making it suitable for research applications in microbiology, particularly in the study of antibiotic resistance mechanisms and the development of new antimicrobial therapies. Its efficacy against various bacterial strains highlights its potential as a valuable tool in the fight against bacterial infections. -
Anti-Bacterial Agent
Thiocillin is a thiopeptide classified as a Ribosomally Synthesized and Post-Translationally Modified Peptide (RiPP) that targets the bacterial 50S ribosomal subunit. It demonstrates significant antibacterial activity against various antibiotic-resistant pathogens, making it a valuable tool in the study of bacterial resistance mechanisms and the development of new antimicrobial therapies. Its effectiveness and unique mechanism of action position thiocillin as a promising candidate for research in infectious disease and antibiotic discovery. -
Anti-Bacterial Agent
Manumycin E is an anti-bacterial agent primarily targeting Gram-positive bacteria, with notable activity against Escherichia coli. It inhibits RAS Faraday base transfer, demonstrating a cytotoxic effect on human cancer cell lines, specifically HCT-116, with an IC50 of 15.6 μg/mL. Due to its limited efficacy against Gram-negative bacteria and fungi, Manumycin E may be primarily utilized in research focused on Gram-positive infections and cancer biology. -
Antibacterial Agent
3-Aminoisonicotinohydrazide is an antibacterial agent that primarily targets Mycobacterium tuberculosis. This compound demonstrates significant inhibitory activity against the pathogen, making it a valuable tool for research into tuberculosis and related infectious diseases. Its efficacy in antibacterial studies supports investigations into new treatment regimens and therapeutic strategies. -
Anti-Bacterial Agent
Azetomycin II is an anti-bacterial agent primarily effective against Gram-positive bacteria. It exhibits potent inhibitory activity against a variety of pathogenic strains, making it a valuable tool in the study of bacterial infections. Azetomycin II is commonly utilized in research focused on antimicrobial resistance and the development of new therapeutic strategies. -
Anti-Bacterial Agent
N-(2,6-Diamino-6-hydroxymethylpimelyl)-L-alanine functions as an anti-bacterial agent, demonstrating significant activity against Escherichia coli. When combined with various cell wall synthesis inhibitors such as Fosfomycin, Cycloserine, Penicillin, and Cephalosporin, it exhibits a pronounced synergistic antibacterial effect. This compound is valuable for research into antibacterial therapies and mechanisms of resistance. -
Anti-Bacterial Agent
Kibdelin D is an anti-bacterial agent that exhibits resistance against Gram-positive bacteria, particularly demonstrating potent activity against Staphylococcus aureus, including methicillin-resistant strains. Its mechanisms of action make it an important candidate for research into alternative treatments for bacterial infections, particularly in the context of increasing antibiotic resistance. -
Antibacterial Agent
cOB1 pheromone is a bacterial sex pheromone that functions as an antibacterial agent. It has been shown to effectively inhibit the growth of multidrug-resistant Enterococcus faecalis V583, making it a valuable tool for research into combating antibiotic resistance. Its unique mechanism of action highlights its potential applications in the study of bacterial communication and resistance mechanisms. -
Antibacterial Agent
CL-55 is an antibacterial agent that inhibits the type three secretion system of Chlamydia trachomatis, preventing the delivery of effector molecules into host cells. This compound has demonstrated efficacy in mitigating C. trachomatis infection and associated inflammation in murine models, highlighting its potential in therapeutic research for sexually transmitted infections. CL-55 serves as a vital tool for studying the pathogenic mechanisms of Chlamydia and developing effective treatment strategies. -
Antibacterial Agent/Photosensitive Agent
Fenticlor is a topical antibacterial agent that primarily targets skin bacteria involved in acne development. This compound is known to elicit photosensitivity reactions, leading to potential phototoxic dermatitis upon exposure to light. Its biological activity makes it useful in dermatological research focused on acne treatments and the mechanisms of skin sensitivity. -
Anti-Bacterial Agent
Pacidamycin 6 is an anti-bacterial agent targeting various bacterial strains, including Pseudomonas aeruginosa, Staphylococcus spp., and Escherichia coli. This compound demonstrates significant inhibitory effects on these pathogens, making it a valuable tool for studying bacterial infections. Notably, its antibacterial activity is influenced by serum components and pH levels, highlighting the importance of environmental conditions in its efficacy. Researchers can utilize Pacidamycin 6 for investigations into antibiotic resistance and bacterial pathogenesis. -
Antibacterial Agent
LY173013 is an antibacterial agent that exhibits broad-spectrum activity against a variety of bacterial strains. It targets penicillin-binding protein 3 (PBP 3) in Escherichia coli, effectively inhibiting bacterial cell wall synthesis. This compound is suitable for research applications in the study of antibacterial mechanisms and potential therapeutics for bacterial infections. -
Bacterial Inhibitor
INF55 is a multidrug resistance pump inhibitor targeting bacterial efflux mechanisms. By inhibiting the NoA pump, INF55 enhances the antibacterial efficacy of compounds such as berberine, reducing their efflux and overcoming bacterial resistance. Structural variants of INF55 demonstrate diverse NoA inhibitory activities, which can influence the antibacterial effectiveness of their respective heterocomplexes. This versatility makes INF55 and its derivatives valuable tools in the study and development of novel antimicrobial strategies. -
Antibacterial Agent
FOL7185 is an antibacterial agent that targets the IspD and IspE enzymes found in bacterial species. This compound exhibits potent inhibitory activity, disrupting critical biochemical pathways involved in bacterial cell wall biosynthesis. FOL7185 is useful for research applications aimed at understanding bacterial resistance mechanisms and developing novel antimicrobial therapies. -
Anti-Bacterial Agent
Pacidamycin 4 is an anti-bacterial agent with a primary mechanism of inhibiting Pseudomonas aeruginosa. It also exhibits activity against several other bacterial strains, including Staphylococcus aureus and Escherichia coli. The antibacterial efficacy of Pacidamycin 4 is influenced by serum and is affected by variations in pH, making it important for researchers to consider these factors in experimental design. This compound is valuable for studies exploring bacterial resistance and the development of novel antimicrobial therapies. -
Anti-Bacterial Agent
Gilvocarcin E is an anti-bacterial agent that primarily targets Gram-positive bacteria. It exhibits significant biological activity against various strains, as well as inhibitory effects on sarcoma 180 and P388 leukemia cells. This compound is valuable for research in microbiology and cancer biology, providing insights into bacterial resistance and potential therapeutic approaches. -
Anti-Bacterial Agent
Fumaryl-DL-alanine, recognized for its antibacterial properties, primarily targets Gram-positive bacteria. This compound exhibits significant activity against bacterial strains, making it a valuable tool for research in antimicrobial efficacy and mechanism of action studies. Its properties facilitate investigations into bacterial resistance and the development of new antibacterial agents. -
Bacterial Inhibitor
Racemomycin B is a potent bacterial inhibitor derived from Streptomyces lavendulae OP-2, characterized as a streptothricin antibiotic with three β-lysine groups. It demonstrates significant antimicrobial activity against plant pathogenic microorganisms, effectively inhibiting the root growth of Brassica rapa L. at a concentration of 50 ppm. Racemomycin B exhibits a minimum inhibitory concentration (MIC) of 0.4 μg/ml against Pseudomonas syringae pv. tabaci IFO-3508 and a MIC range of 0.1-2.0 μg/ml against various strains of Fusarium oxysporum. The biological efficacy of this compound is enhanced by the increasing number of β-lysine groups, making it a valuable tool for agricultural research. -
Anti-Bacterial Agent
Glysperin C is an anti-bacterial agent targeting both Gram-positive and Gram-negative bacteria, including those resistant to aminoglycoside antibiotics. Its broad-spectrum activity makes it a valuable tool for research into bacterial resistance mechanisms and the development of new therapeutic strategies against various infectious diseases. -
Antibacterial Agent
Octenidine (saccharin) is a potent antibacterial agent that targets multidrug-resistant Gram-negative pathogens. This compound exhibits significant activity by inhibiting the expression of biofilm-associated genes, which disrupts biofilm formation. Its unique properties make it valuable for research applications focused on combating antibiotic resistance and biofilm-related infections. -
Anti-Bacterial Agent
Diatretyne I is an anti-bacterial agent that exhibits selective activity against Gram-positive bacteria. This compound demonstrates potential in addressing bacterial infections and may serve as a valuable tool in microbiological research for evaluating antibacterial efficacy and understanding resistance mechanisms. -
Anti-Bacterial Agent
Galacardin B is an anti-bacterial agent that specifically targets Gram-positive bacteria. It exhibits potent bactericidal activity, making it valuable in research focused on developing treatments for infections caused by resistant bacterial strains. This compound serves as a critical tool for scientists investigating antibacterial mechanisms and therapeutic options in microbiology. -
Antibacterial Agent
Palmitanilide is an antibacterial agent that specifically targets Gram-positive bacteria. It exerts its activity by electrostatically binding to components within the bacterial cell wall, leading to alterations in cell membrane structure and disruption of normal cell functions. This compound shows promise for research applications focused on infectious diseases caused by Gram-positive pathogens, such as Bacillus cereus. -
Anti-Bacterial Agent
Fosfocytocin is an antibacterial agent derived from the strain of Pseudomonas fluorescens PK-52. It exhibits low antibacterial activity, making it a subject of interest for studying bacterial resistance mechanisms. This compound may serve as a valuable tool in research applications focused on antimicrobial peptides and their interactions with bacterial pathogens. -
Anti-Bacterial Agent
Chlorocardicin is a monocyclic beta-lactam antibiotic that primarily targets bacterial cell wall synthesis. It demonstrates moderate in vitro activity against Enterobacteriaceae and Pseudomonas aeruginosa, making it a valuable tool for studying bacterial infections and resistance mechanisms. This compound is applicable in research focused on antibiotic development and evaluating the efficacy of beta-lactam antibiotics. -
Anti-Bacterial Agent
15-Deoxy-15-oxolankamycin is an anti-bacterial agent with a specific mechanism targeting Gram-positive bacteria. This compound exhibits weak antibacterial activity, making it a valuable tool for studying bacterial resistance and the efficacy of antibiotics. Its applications extend to microbiological research, where it can aid in the investigation of bacterial growth and response to various treatments. -
Anti-Bacterial Agent
Ditrisarubicin A is an anti-bacterial agent with demonstrated efficacy against Gram-positive bacteria. In addition to its antibacterial properties, it exhibits cytotoxic effects on L-1210 cells, highlighting its potential in cancer research. This compound can be utilized in studies aimed at understanding bacterial resistance mechanisms and evaluating therapeutic strategies for both bacterial infections and cancer. -
Anti-Bacterial Agent
Oganomycin GB is an antibacterial agent derived from the fermentation of Streptomyces str. oganonensis Y-G 19Z. It exhibits potent activity against both Gram-positive and Gram-negative bacteria, demonstrating stability and efficacy superior to its precursor compounds. Oganomycin GB's mechanism involves the inhibition of D-amino acid oxidase, leading to alterations in metabolic pathways that enhance its antibacterial properties. This reagent is valuable for research in microbiology and antibiotic development. -
Antibacterial Agent
Aldgamycin F is an antibacterial agent that exhibits potent antimicrobial activity through its interaction with bacterial ribosomes, inhibiting protein synthesis. This compound is primarily used in research focused on developing new antibiotics and studying mechanisms of bacterial resistance. Its effectiveness against various bacterial strains makes it a valuable tool in microbiological and pharmaceutical investigations. -
Anti-Bacterial Agent
Cladospolide A is a natural compound derived from the fungus Cladosporium sp. FT-0012, exhibiting potential anti-bacterial properties. Although its antibacterial activity is limited, it serves as a valuable tool for research into microbial interactions and the development of novel antimicrobial strategies. Further studies can explore its specific mechanisms and applications in the field of infectious disease research. -
Bacterial Inhibitor
(R,R)-Ethambutol is a bacterial inhibitor primarily targeting Mycobacterium tuberculosis, exhibiting significant antituberculosis activity. It is commonly utilized in combination therapies to enhance the therapeutic efficacy against tuberculosis. Additionally, (R,R)-Ethambutol demonstrates effectiveness in inhibiting infections caused by Mycobacterium avium complex and Mycobacterium kansasii, making it a valuable reagent for research in mycobacterial infections. -
Bacterial Regulator
N-Pentadecanoyl-L-homoserine lactone is an N-acyl homoserine lactone that functions as a bacterial regulator. It acts as a signaling molecule involved in quorum sensing, enabling bacteria to coordinate group behaviors based on population density. This compound is utilized in research to study bacterial communication and the regulation of virulence factors, offering insights into microbial pathogenesis and potential therapeutic interventions. -
Bacterial Mutagenic Compound
Catalpin is an iridoid compound derived from Catalpae Fructus, known for its mutagenic activity. It exhibits significant mutagenicity towards the Salmonella typhimurium strain TA100, making it a valuable reagent for studying bacterial mutation mechanisms. This compound is useful in research applications focused on mutagenesis and the assessment of genetic variations induced by environmental factors. -
Anti-Bacterial Agent
Istamycin B is an anti-bacterial agent that demonstrates potent activity against both Gram-positive and Gram-negative bacteria. Its mechanism of action involves disrupting bacterial cell wall synthesis, leading to cell lysis and death. This compound is valuable for research applications focusing on developing new antibiotics and understanding bacterial resistance mechanisms. -
Anti-Bacterial Agent
Cephamycin B is a β-lactam antibiotic that exerts its antibacterial effects by inhibiting bacterial cell wall synthesis. It demonstrates moderate activity against both Gram-positive and Gram-negative bacteria. This compound is particularly useful in microbiological research for studying antibiotic resistance and bacterial growth dynamics. -
Antibacterial Agent
K13787 is an acetohydroxyacid synthase (AHAS) inhibitor that exhibits antibacterial activity. This compound demonstrates efficacy against a range of nontuberculous mycobacteria (NTM) and strains resistant to clarithromycin. K13787 is valuable for research involving antibacterial resistance mechanisms and the development of new therapeutic agents targeting mycobacterial infections. -
Antimycobacterial Agent
Antitubercular agent-57 is a selective antimycobacterial agent targeting Mycobacterium tuberculosis. It demonstrates significant efficacy against both drug-sensitive and multidrug-resistant strains, including extensively drug-resistant variants, while maintaining low toxicity towards mammalian cell lines, such as hepatocytes. Antitubercular agent-57 exhibits no cross-resistance with established first and second-line antitubercular agents and shows no antimicrobial activity against Gram-positive and Gram-negative bacteria or fungal strains. This reagent is valuable for research focused on tuberculosis and multidrug-resistant tuberculosis. -
Anti-Bacterial Agent
Chrysospermin A is an antibacterial agent with demonstrated activity against various Gram-positive bacteria, including Staphylococcus aureus and Bacillus subtilis, as well as against Klebsiella pneumoniae. Additionally, it exhibits inhibitory effects on individual yeast species such as Ocher echinoderma and Saccharomyces cerevisiae. This compound is valuable for research applications focused on the development of antibacterial therapies and the study of antimicrobial resistance. -
Antibacterial Agent
LL-BM123γ2 is an antibacterial agent that exhibits activity against a broad spectrum of microorganisms. Its efficacy makes it suitable for research applications focused on understanding antibacterial mechanisms and developing new therapeutic strategies. -
Anti-Bacterial Agent
Cinerubin R is an anti-bacterial agent that exhibits potent activity against Gram-positive bacteria. Additionally, it demonstrates inhibitory effects on tumor cell proliferation and is effective against multidrug-resistant (MDR) cells, displaying similar inhibitory potency to protocells. This compound is valuable for research in antibacterial therapies and cancer treatment strategies. -
Anti-Bacterial Agent
Basidalin is an anti-bacterial agent exhibiting activity against both Gram-positive and Gram-negative bacteria. It has demonstrated efficacy in inhibiting the proliferation of mouse leukemia L-1210 cells, making it a valuable tool for research in microbiology and oncology. Its broad-spectrum antibacterial properties and potential antitumor activity support various applications in experimental studies related to infectious diseases and cancer research. -
Anti-Bacterial Agent
Ochracenomicin C is an antibacterial agent derived from the strain Amicolatopsis sp. MJ 950-891. It exhibits moderate antibacterial activity, demonstrating potential utility in studying antibiotic resistance and the mechanisms of bacterial growth inhibition. This compound may serve as a valuable tool in research focused on developing new antibacterial strategies. -
Anti-Bacterial Agent
Ilicicolin B is a potent anti-bacterial agent that specifically inhibits Bacillus carbonifera at a concentration of 6 μg/mL. Its selectivity is highlighted by a toxic concentration of 0.3 μg/mL in HeLa cells. This compound is valuable for research on bacterial infections and the study of bacterial resistance mechanisms. -
Anti-Bacterial Agent
Cinnatriacetin B is a natural compound derived from the fungus Fistulina hepatica, primarily exhibiting anti-bacterial activity against Gram-positive bacteria. Its unique mechanism of action makes it a valuable agent for studying bacterial inhibition and resistance mechanisms. Cinnatriacetin B is applicable in microbiological research and offers potential insights into the development of novel antibacterial therapies.
